- Home
- OXLC vs CLDX Comparison
OXLC vs CLDX Comparison
Compare OXLC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLC
- CLDX
- Stock Information
- Founded
- OXLC 2010
- CLDX 1983
- Country
- OXLC United States
- CLDX United States
- Employees
- OXLC N/A
- CLDX N/A
- Industry
- OXLC Investment Managers
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OXLC Finance
- CLDX Health Care
- Exchange
- OXLC Nasdaq
- CLDX Nasdaq
- Market Cap
- OXLC 1.8B
- CLDX 1.7B
- IPO Year
- OXLC N/A
- CLDX 2008
- Fundamental
- Price
- OXLC $5.05
- CLDX $22.46
- Analyst Decision
- OXLC Strong Buy
- CLDX Buy
- Analyst Count
- OXLC 1
- CLDX 8
- Target Price
- OXLC $6.00
- CLDX $61.86
- AVG Volume (30 Days)
- OXLC 1.9M
- CLDX 774.1K
- Earning Date
- OXLC 11-01-2023
- CLDX 03-04-2025
- Dividend Yield
- OXLC 18.86%
- CLDX N/A
- EPS Growth
- OXLC N/A
- CLDX N/A
- EPS
- OXLC 1.20
- CLDX N/A
- Revenue
- OXLC $130,145,365.00
- CLDX $9,976,000.00
- Revenue This Year
- OXLC $136.15
- CLDX N/A
- Revenue Next Year
- OXLC $5.51
- CLDX N/A
- P/E Ratio
- OXLC $4.24
- CLDX N/A
- Revenue Growth
- OXLC N/A
- CLDX 128.55
- 52 Week Low
- OXLC $4.41
- CLDX $20.91
- 52 Week High
- OXLC $5.70
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- OXLC 40.33
- CLDX 42.55
- Support Level
- OXLC $5.05
- CLDX $22.38
- Resistance Level
- OXLC $5.14
- CLDX $23.69
- Average True Range (ATR)
- OXLC 0.04
- CLDX 1.07
- MACD
- OXLC -0.00
- CLDX 0.03
- Stochastic Oscillator
- OXLC 6.67
- CLDX 44.67
About OXLC Oxford Lane Capital Corp.
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.